News

Atherosclerosis, characterized by the buildup of plaque inside human arteries, is one of the leading causes of cardiovascular diseases. The disease is brought on by a complex interplay between lipids, inflammatory cells, and the ECM. Arterial blood flow is restricted as plaques form, which can rupture to cause blockage. Arterial blockage, or occlusion, is...

3Helix is thrilled to announce the addition of three new members to our talented team.  These new members bring with them experience and expertise that will contribute to our continued success. It is our pleasure to introduce Regan, Keelah, and Anthony to you all. Please help us congratulate them on joining our team! We...

Innovation partnership builds on 3Helix’s breakthrough developments in collagen-hybridizing peptide (CHP) technology. BASF to exclusively commercialize 3Helix’s technology to introduce CHP innovation to the personal care market. BASF will join 3Helix Board of Directors. Advancing BASF Care Chemicals’ Care 360° – Solutions for Sustainable Life Ludwigshafen, Germany and Salt Lake City, Utah, USA, November...